Literature DB >> 7453194

Quantitative estimation of overadditive and underadditive drug effects by means of theoretical, additive dose-response curves.

G Pöch, S Holzmann.   

Abstract

A graphical method is described that permits simple and adequate quantitative and statistical evaluation of combinations of synergistically acting drugs. Thereby, the dose-response (DR) of a drug A can be determined in the presence as well as in the absence of a certain concentration of a drug B. The effects of A + B combined are expressed as combined (total) effects related to the control value before addition of B. The DR curve obtained in this manner is compared with a theoretical DR curve of additive synergism, which can be constructed simply. This procedure allows differentiation of overadditive or underadditive from additive interactions of A + B and the quantitation of nonadditive drug effects. DR curves of additive interaction coincide with the respective theoretical additive DR curve. Overadditive DR curves are characterized by a left shift from the theoretical additive DR curve that can be expressed by a dose factor. Increased maximum effects of A + B over A can be treated statistically (t-test). Underadditive DR curves show a shift to the right from the theoretical additive DR curve that can likewise be expressed by a dose factor. Decreased effects of A + B below the maximum of A can likewise be treated by t-test. The quantitative expression of overadditive drug interactions further allows differentiation between sequential and functional synergism, the DR curve of the latter can also be constructed simply. The application of this method to experiments with isolated coronary arteries had yielded examples of additive, overadditive, and underadditive drug interactions. The method appears to be a superior alternative to the isoboles method of Loewe and Muischnek (1926).

Mesh:

Substances:

Year:  1980        PMID: 7453194     DOI: 10.1016/0160-5402(80)90036-4

Source DB:  PubMed          Journal:  J Pharmacol Methods        ISSN: 0160-5402


  16 in total

1.  Synergy between verapamil and other multidrug -resistance modulators in model membranes.

Authors:  Madeleine Castaing; Alain Loiseau; Athel Cornish-Bowden
Journal:  J Biosci       Date:  2007-06       Impact factor: 1.826

2.  Combining naltrexone and prazosin in a single oral medication decreases alcohol drinking more effectively than does either drug alone.

Authors:  Janice C Froehlich; Brett J Hausauer; Dennis D Rasmussen
Journal:  Alcohol Clin Exp Res       Date:  2013-07-22       Impact factor: 3.455

3.  Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase.

Authors:  B E Crack; C E Pollard; M W Beukers; S M Roberts; S F Hunt; A H Ingall; K C McKechnie; A P IJzerman; P Leff
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

4.  Evidence for bidirectional endocannabinoid transport across cell membranes.

Authors:  Andrea Chicca; Janine Marazzi; Simon Nicolussi; Jürg Gertsch
Journal:  J Biol Chem       Date:  2012-08-09       Impact factor: 5.157

5.  Evidence for cyclic GMP-mediated relaxant effects of nitro-compounds in coronary smooth muscle.

Authors:  W R Kukovetz; S Holzmann; A Wurm; G Pöch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

6.  Studies using isolated uterine and other preparations show bimatoprost and prostanoid FP agonists have different activity profiles.

Authors:  June Chen; Judith Senior; Kay Marshall; Farhat Abbas; Helen Dinh; Tim Dinh; Larry Wheeler; David Woodward
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

7.  Synergistic interaction between histamine and ouabain on ventricular fibrillation threshold.

Authors:  J P Trzeciakowski
Journal:  Br J Pharmacol       Date:  1985-05       Impact factor: 8.739

8.  Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery.

Authors:  S J Lydford; K C McKechnie; I G Dougall
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

9.  Mixture toxicity of SN2-reactive soft electrophiles: 3. Evaluation of ethyl α-halogenated acetates with α-halogenated acetonitriles.

Authors:  D A Dawson; G Pöch; T W Schultz
Journal:  Arch Environ Contam Toxicol       Date:  2013-12-25       Impact factor: 2.804

10.  Investigations differentiating the mechanism of specific bradycardic agents from that of calcium channel blockers.

Authors:  C Lillie; W Kobinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.